HSIC · Henry Schein Inc · Executive Compensation

$84.16 -0.36 (-0.42%) Q2 2026 earnings call transcript

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$9.42B

111.45M

Volume · Oct 27 401.69K Avg daily vol (3M) 1.2M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stanley Bergman	CEO	$1,625,335	$0	$7,395,000	$0	$643,652	$341,742	$10,005,729
Stanley M. Bergman	Chairman and Chief Executive Officer (Principal Executive Officer)	$1,625,335	$0	$7,395,000	$0	$643,652	$341,742	$10,005,729
Mark E. Mlotek	Executive Vice President and Chief Strategic Officer	$688,242	$0	$1,870,000	$0	$597,065	$61,917	$3,217,224
Michael S. Ettinger	Executive Vice President and Chief Operating Officer	$670,804	$0	$1,792,000	$0	$447,982	$57,766	$2,968,552
James P. Breslawski	Vice Chairman, President	$866,992	$0	$1,250,000	$0	$498,920	$77,005	$2,692,917
Ronald South	Senior Vice President, Chief Financial Officer (Principal Financial Officer)	$586,038	$0	$1,350,000	$0	$363,012	$52,026	$2,351,076
Ronald N. South	Senior Vice President, Chief Financial Officer (Principal Financial Officer)	$586,038	$0	$1,350,000	$0	$363,012	$52,026	$2,351,076

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stanley Bergman	CEO	$1,571,554	$0	$3,176,804	$794,196	$2,321,378	$391,203	$8,255,135
Stanley M. Bergman	Chairman and Chief Executive Officer (Principal Executive Officer)	$1,571,554	$0	$3,176,804	$794,196	$2,321,378	$391,203	$8,255,135
James P. Breslawski	Vice Chairman, President	$831,661	$0	$1,452,800	$363,200	$832,274	$84,918	$3,564,853
Mark E. Mlotek	Executive Vice President and Chief Strategic Officer	$658,819	$0	$1,480,007	$369,993	$692,150	$65,798	$3,266,767
Ronald N. South	Senior Vice President, Chief Financial Officer (Principal Financial Officer)	$520,064	$0	$1,600,042	$399,958	$527,235	$50,113	$3,097,412
Ronald South	Senior Vice President, Chief Financial Officer (Principal Financial Officer)	$520,064	$0	$1,600,042	$399,958	$527,235	$50,113	$3,097,412

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stanley Bergman	CEO	$1,534,262	$0	$4,257,489	$1,512,720	$3,243,324	$238,385	$10,786,180
Stanley M. Bergman	Chairman and Chief Executive Officer (Principal Executive Officer)	$1,534,262	$0	$4,257,489	$1,512,720	$3,243,324	$238,385	$10,786,180
James P. Breslawski	Vice Chairman, President	$798,642	$0	$1,628,311	$691,680	$1,104,178	$92,221	$4,315,032
Mark E. Mlotek	Executive Vice President and Chief Strategic Officer	$629,938	$0	$1,424,419	$605,000	$783,424	$80,740	$3,523,521

Executive changes

Person	Role	Change	Effective	Filed
Emmanuel Caprais	Senior Vice President, Chief Financial Officer	Appointed	2026-11-04	2026-10-08
Frederick M. Lowery	Board of Directors	Appointed	2026-03-02	2026-01-12
Frederick M. Lowery	Chief Executive Officer	Appointed	2026-03-02	2026-01-12
Mr. Stanely M. Bergman	Chief Executive Officer	Retired	2026-03-02	2026-01-12
Frederick Lowery	member of the Board of Directors	Appointed	2026-03-02	2026-01-12
Frederick Lowery	Chief Executive Officer	Appointed	2026-03-02	2026-01-12
Stanley M. Bergman	Chief Executive Officer	Retired	2025-12-31	2025-07-15
William K. "Dan" Daniel	director	Appointed	2025-05-16	2025-05-16
Max Lin	director	Appointed	2025-05-02	2025-05-02
James P. Breslawski	Senior Advisor	Appointed	2025-04-01	2025-03-14
Robert J. "Bob" Hombach	independent director	Appointed	—	2025-01-29
William K. "Dan" Daniel	independent director	Appointed	—	2025-01-29
Dan Daniel	member of the Board	Appointed	—	2025-01-29
Max Lin	member of the Board	Appointed	—	2025-01-29
Robert J. Hombach	director	Appointed	2025-01-27	2025-01-29
Reed V. Tuckson	director	Appointed	2024-05-21	2024-05-24
Bradley T. Sheares	director	Appointed	2024-05-21	2024-05-24
Scott Serota	director	Appointed	2024-05-21	2024-05-24
Carol Raphael	director	Appointed	2024-05-21	2024-05-24
Mark E. Mlotek	director	Appointed	2024-05-21	2024-05-24
Anne H. Margulies	director	Appointed	2024-05-21	2024-05-24
Kurt P. Kuehn	director	Appointed	2024-05-21	2024-05-24
Philip A. Laskawy	director	Appointed	2024-05-21	2024-05-24
Joseph L. Herring	director	Appointed	2024-05-21	2024-05-24
Carole T. Faig	director	Appointed	2024-05-21	2024-05-24

Leadership

Andrea Albertini CEO
Frederick Lowery CEO, Board Member
Frederick M. Lowery CEO, Board Member
R. Steven Boggan CEO
Stanley Bergman CEO, Board Member
Tom Popeck CEO
James P. Breslawski Chairman, Board Member
Emmanuel Caprais CFO
Ronald N. South CFO, Chief Accounting Officer
Ronald South CFO, Chief Accounting Officer
Michael S. Ettinger COO
Christopher Pendergast CTO
Kelly Murphy General Counsel
Anne H. Margulies Board Member
Bradley T. Sheares, Ph.D. Board Member
Carole T. Faig Board Member
Dan Daniel Board Member
Deborah Derby Board Member
E. Dianne Rekow, DDS, Ph.D. Board Member
Kurt P. Kuehn Board Member
Max Lin Board Member
Mohamad Ali Board Member
Paul Brons Board Member
Philip A. Laskawy Board Member
Reed V. Tuckson Board Member
Reed V. Tuckson, M.D., FACP Board Member
Robert J. "Bob" Hombach Board Member
William K. "Dan" Daniel Board Member

Key facts CIK 1000228 CUSIP 806407102 13F (30d) 135 filings 129 filers Visit website Investor relations